The IUSS Crohn's Study: A Feasibility Study
Assessing the Feasibility and Safety of Using Intraoperative Ultrasound in Ileocolic Crohn's Disease - The IUSS Crohn's Feasibility Study
1 other identifier
observational
6
1 country
1
Brief Summary
The aim of this study is to evaluate if an intraoperative protocol for Ultrasound scan (USS) is feasible and safe in patients undergoing elective surgery for ileocolic CD. The results of this study could guide the development of a larger randomised trial.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Jan 2019
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 19, 2019
CompletedFirst Submitted
Initial submission to the registry
March 26, 2019
CompletedFirst Posted
Study publicly available on registry
May 6, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 9, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
March 9, 2020
CompletedJune 22, 2020
June 1, 2020
1.1 years
March 26, 2019
June 19, 2020
Conditions
Outcome Measures
Primary Outcomes (9)
Number of intraoperative USS assessments completed.
Recording the number of intraoperative surgery completed
Day of surgery
Number of adverse events reported during surgery.
Recording the number of adverse events reported during the surgey
Day of surgery
To record the incidence of crohn's disease identified at macroscopic intraoperative assessment of the small bowel by the surgeon, and the intraoperative USS assessment of the small bowel.
recording the incidence of crohn's disease identified following assessment of the small bowel by the surgeon macroscopcially
Day of surgery
To record the length of areas affected by crohn's disease identified at macroscopic intraoperative assessment of the small bowel by the surgeon
Measurement in centimeters of the length of bowel affected by crohn's disease as identified by the surgeon macroscopically
Day of surgery
To compare the incidence of crohn's disease indentified macroscopically by the surgeon with the intraoperative ultrasound assessment
compare the incidence of crohn's disease identified by the surgeon with the incidence of crohn's disease identified by the intraoperative ultrasound assessment
Day of surgery
To compare the length of crohn's disease identified marcoscopically by the surgeon with the intraoperative ultrasound assessment
compare the length of crohn's disease in centimetres identified by the surgeon with the incidence of crohn's disease identified by the intraoperative ultrasound assessment
Day of surgery
To evaluate the feasibility of study delivery, i.e. recruitment of study participants and retention at follow-up visits.
Feasibility of data collection required for a future trial measured by number of eligible participants, the proportion of patients consenting for the study, the proportion of recruited participants with all the required baseline and follow-up assessments completed, proportion of withdrawals from follow-up data collection, reasons for withdrawal and number of losses to follow-up.
6 week follow up
To record surgical and patient outcomes up to 6 weeks
Operating time (Kaplan-Meier analysis), intra- and post-operative complication rates, 30 day morbidity and mortality rate
30 day morbidity
To evaluate the direct and indirect costs of a standardised intraoperative USS protocol.
Annotation of key steps for performance of small bowel intraoperative USS in patients with CD.
1 year
Eligibility Criteria
The target population is adults (18+ years) undergoing elective surgery (i.e. planned operation) for CD affecting the small bowel.
You may qualify if:
- Aged 18 years or over
- American society of Anaesthesiologists (ASA) grade I, II or III
- Undergoing elective surgery to remove part of the terminal ileum which is affected by CD.
- Indication for surgery agreed at IBD MDT meeting
- Able to give written informed consent
You may not qualify if:
- Undergoing emergency surgery
- Previous abdominal surgery for CD
- Pregnant
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Portsmouth Hospitals NHS Trust
Portsmouth, Hampshire, PO6 3LY, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Valerio Celentano
Portsmouth Hospitals NHS Trust
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 26, 2019
First Posted
May 6, 2019
Study Start
January 19, 2019
Primary Completion
March 9, 2020
Study Completion
March 9, 2020
Last Updated
June 22, 2020
Record last verified: 2020-06